Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014
| Format: | Électronique Revue |
|---|---|
| Langue: | anglais |
| Publié: |
MarketLine, a Progressive Digital Media business
|
| Accès en ligne: | Full text available on EBSCOhost[Apr 2014- |
Documents similaires
Pfizer Case Study: Protecting Blockbuster Drugs from Generic Competition
Epics, Spectacles, and Blockbusters
par: Neale
par: Neale
Patently Mathematical
par: Suzuki
par: Suzuki
Patent Journal
Blockbuster History in the New Russia
par: Norris
par: Norris
Blockbuster, Inc. SWOT Analysis
Teva Pharmaceutical Industries SWOT Analysis
The Shame of Losing
par: Cannon
par: Cannon
Losing Beck
par: Hahn
par: Hahn
Losing Ground
par: Burley
par: Burley
Losing the Center
par: Bloodworth
par: Bloodworth
Losing Vietnam
par: Hunt
par: Hunt
Nothing to Lose
par: Sanderson
par: Sanderson
Free to lose.
par: Roemer, John E
Publié: (1988)
par: Roemer, John E
Publié: (1988)
The art of losing.
par: Zeniter, Alice
Publié: (2021)
par: Zeniter, Alice
Publié: (2021)
Free to lose.
par: Roemer, John E
Publié: (1988)
par: Roemer, John E
Publié: (1988)
India and the Patent Wars
par: Halliburton
par: Halliburton
World Patent Information
Pharmaceutical Patent Analyst
Teva Pharmaceutical Industries Limited SWOT Analysis
Expert Opinion on Therapeutic Patents
Losing Touch with Nature
par: Crane
par: Crane
So Much to Lose
par: Rust
par: Rust
Losing Binh Dinh
par: Boylan
par: Boylan
Losing Hearts and Minds
par: Shannon
par: Shannon
Just Who Loses?
par: Lucas
par: Lucas
Winning While Losing
par: White
par: White
Losing america : confronting a reckless and arrogant presidency /
par: Byrd, Senator Robert C.
Publié: (2004)
par: Byrd, Senator Robert C.
Publié: (2004)